Equity Real Estate Investment Trusts (REITs)

Chiron Real Estate

Chiron Real Estate released FY2026 Q1 earnings on May 6 After-Market EST, actual revenue USD 38.05 M (forecast USD 38.09 M), actual EPS USD -0.06 (forecast USD 0.0033)

Chiron Real Estate Acquires Senior Housing Properties for $425 Million

Chiron Real Estate to Release FY2026 Q1 Earnings on May 6 After-Market EST, Forecast Revenue USD 38.09 M, EPS USD 0.0033

Chiron Real Estate released FY2025 Q4 earnings on February 25 After-Market EST, actual revenue USD 38.39 M (forecast USD 37.44 M), actual EPS USD -0.5548 (forecast USD 0.065)

Chiron Real Estate released FY2025 earnings on February 25 After-Market EST, actual revenue USD 148.06 M (forecast USD 146.42 M), actual EPS USD -0.9055 (forecast USD -0.26)

Chiron Real Estate released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 37.2 M (forecast USD 38.15 M), actual EPS USD -0.448 (forecast USD 0.045)

Chiron Real Estate Inc. released FY2024 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 103.62 M and EPS of USD -0.0536

Chiron Real Estate released FY2024 Q3 earnings on November 5, 2025 (EST), actual revenue USD 34.26 M (forecast USD 34.65 M), actual EPS USD 0.1362

Chiron Real Estate released FY2025 9 Months Earnings on November 5, 2025 (EST), actual revenue USD 109.69 M, actual EPS USD -0.3578

Chiron Real Estate released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 37.92 M (forecast USD 35.57 M), actual EPS USD -0.0598 (forecast USD 0.05)

Chiron Real Estate released FY2025 Semi-Annual Earnings on August 6, 2025 (EST), with actual revenue of USD 72.5 M and EPS of USD 0.0974

Chiron Real Estate released FY2024 Semi-Annual Earnings on August 6, 2025 (EST), with actual revenue of USD 69.36 M and EPS of USD -0.1794

CHIRON REAL ESTATE INC released FY2024 Q2 earnings on August 6, 2025 (EST), actual revenue USD 34.24 M (forecast USD 34.25 M), actual EPS USD -0.2399

Chiron Real Estate released FY2024 Q1 earnings on May 8 (EST), actual revenue USD 35.12 M (forecast USD 34.68 M), actual EPS USD 0.05

Chiron Real Estate released FY2025 Q1 earnings on May 8 (EST), actual revenue USD 34.58 M (forecast USD 35.49 M), actual EPS USD 0.15 (forecast USD 0.0625)

Chiron Real Estate released FY2024 Annual Earnings on February 28 (EST), actual revenue USD 138.76 M (forecast USD 138.76 M), actual EPS USD 0.0614

Chiron Real Estate released FY2023 Q4 earnings on February 28 (EST), actual revenue USD 32.96 M (forecast USD 35.75 M), actual EPS USD -0.064

CHIRON REAL ESTATE INC released FY2022 earnings on February 28 (EST), actual revenue USD 137.28 M (forecast USD 136.77 M), actual EPS USD 1.0173

Chiron Real Estate released FY2023 earnings on February 28 (EST), actual revenue USD 141.05 M (forecast USD 143.85 M), actual EPS USD 1.1281

Chiron Real Estate released FY2024 Q4 earnings on February 28 (EST), actual revenue USD 35.14 M (forecast USD 34.87 M), actual EPS USD 0.1027

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

Micware

BiomX

Vida Global

MetaVia

MicroAlgo

Tradr 2X Long XNDU Daily ETF

Ordinary dividend (cash)

Ex Date: Today 2026.05.20 (EST), Cash dividend 0.25 USD

Chiron Real Estate (XRN) executives have recently engaged in significant insider buying, with three leaders acquiring thousands of shares. Notably, Director Lori Wittman purchased 2,940 shares for $99,489. This activity reflects growing confidence in the company's future, especially as it shifts towards senior housing backed by a $100M private placement. Analysts have mixed views on XRN, citing concerns over financial quality and a bearish technical setup, leading to a Neutral rating from TipRanks’ AI Analyst. The stock has a market cap of $493.8M and a year-to-date price performance of 2.56%.

Tip Ranks

CHIRON REAL ESTATE INC 7.50% CUM RED PREF SER A USD25

CHIRON REAL ESTATE INC 8.00% SERIES B CUM RED PREF STK USD25

Top Chiron Real Estate Leaders Quietly Load Up on Company Stock

Mark Okey Decker, Jr., CEO of Global Medical REIT Inc. (NYSE:XRN), purchased 5,000 shares at $33.94 each, totaling $169,700, increasing his ownership by 9.13% to 59,774 shares valued at $2,028,729.56. The transaction was disclosed to the SEC. The company recently announced a monthly dividend of $0.16, with a yield of 5.6%. Analysts have mixed ratings on the stock, with an average price target of $39.67. Institutional investors hold 57.52% of the stock, reflecting significant interest in the company.

Market Beat

Fifth Third Bancorp

AST SpaceMobile

Axon Enterprise

Apple

Fifth Third Bancorp Pref Share FITBO 4.95 Perp 09/30/24 K

FIFTH THIRD BANK PREF SHARE FITB V6.625 P12/31/49 I

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

Fifth Third Bancorp Depositary Shs B Ser A Repr 1/40 6 % Perp Pfd Registered Shs B Ser A

Mark Okey Decker, Jr. Purchases 5,000 Shares of Global Medical REIT (NYSE:XRN) Stock

Chiron Real Estate (XRN) executives have shown strong confidence through recent insider buying, with CFO Robert Kiernan purchasing 3,000 shares, CEO Mark Okey Jr Decker acquiring 5,000 shares, and COO Holley Danica buying 1,490 shares. This follows a strategic shift from outpatient medical offices to senior housing communities and a reset of dividends. Analysts express concerns over transition risks and financial quality, leading to a Neutral rating from TipRanks’ AI Analyst, Spark. Chiron's current market cap is $492.1M, with a year-to-date price performance of 0.84%.

Top Brass Makes Bold Move With Fresh Insider Buying Spree at Chiron Real Estate ate

Chiron Real Estate Inc. has announced a private placement to raise up to $100 million by issuing 1,000,000 shares of 6.00% Series C Convertible Perpetual Preferred Stock at $100 per share. The funds will be used for general corporate needs and potential acquisitions. The deal includes board representation for Maewyn XRN LP and introduces a complex capital structure. Analysts rate XRN stock as a Buy with a $40.00 price target, though Spark's AI Analyst gives it a Neutral score due to financial concerns. Chiron focuses on real estate investments and has a market cap of $464.6M.

Chiron Real Estate Raises Capital via Preferred Stock Placement

Colliers Securities analyst Barry Oxford has maintained a Buy rating on Chiron Real Estate (XRN) with a price target of $40.00. Oxford, a 4-star analyst, has an average return of 5.0% and a 58.01% success rate. Chiron also received a Buy rating from Alliance Global Partners, while Compass Point downgraded it to a Hold yesterday.

Independence Realty Trust

NNN REIT

Sun Communities

Chiron Real Estate ate (XRN) Receives a Buy from Colliers Securities

Chiron Real Estate shares are trading lower after the company elected to withdraw its FY2026 guidance. Also, Compass Point downgraded the stock from Buy to Neutral and lowered its price target from $50 to $38.

benzinga_article

Global Medical REIT Inc. (NYSE:XRN) has declared a monthly dividend of $0.16 per share, payable on July 17th to shareholders of record as of June 22nd. This dividend represents an annualized yield of 5.4%. The company has a high dividend payout ratio of 6,000%, indicating reliance on its balance sheet for dividend payments. Currently, the stock is trading at $35.60, with a market cap of $471.04 million and a P/E ratio of -39.56. Global Medical REIT focuses on healthcare-related properties across the U.S.

Global Medical Reit

GLOBAL MEDICAL REIT INC 7.50% CUM RED PREF SER A USD25

GLOBAL MEDICAL REIT INC 8.00% SERIES B CUM RED PREF STK USD25

Global Medical REIT Inc. to Issue Monthly Dividend of $0.16 (NYSE:XRN)

Earnings Watch

Chiron Real Estate | 8-K: FY2026 Q1 Revenue: USD 38.06 M

Chiron Real Estate(XRN.US)